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Identification of HIV transmitting CD11c+ human
epidermal dendritic cells
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Langerhans cells (LC) are thought to be the only mononuclear phagocyte population in the
epidermis where they detect pathogens. Here, we show that CD11c+ dendritic cells (DCs) are
also present. These cells are transcriptionally similar to dermal cDC2 but are more efficient
antigen-presenting cells. Compared to LCs, epidermal CD11c+ DCs are enriched in anogenital
tissues where they preferentially interact with HIV, express the higher levels of HIV entry
receptor CCR5, support the higher levels of HIV uptake and replication and are more efficient
at transmitting the virus to CD4 T cells. Importantly, these findings are observed using both a
lab-adapted and transmitted/founder strain of HIV. We also describe a CD33low cell popu-
lation, which is transcriptionally similar to LCs but does not appear to function as antigen-
presenting cells or acts as HIV target cells. Our findings reveal that epidermal DCs in ano-
genital tissues potentially play a key role in sexual transmission of HIV.
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Mononuclear phagocytes (MNP) are antigen-presentingcells (APCs) and represent the first line of contactbetween the immune system and invading pathogens in
the tissues that form the portals of pathogen entry. In the case of
sexually transmitted pathogens, such as HIV, these are the genital
and anorectal (anogenital) tracts which are made up of various
tissues comprised of either skin or mucosal tissue. Skin (outer
foreskin, glans penis and labia) and type II mucosal tissues (inner
foreskin, vagina, ectocervix, fossa navicularis and anal canal) both
contain a stratified squamous epithelium predominantly made up
of keratinocytes, which forms a formidable physical barrier
against invading pathogens. However, HIV penetration and
infection across this surface has been demonstrated in human
ex vivo genital tissue explants from the vagina, ectocervix and
foreskin1–6.
Although several subsets of MNPs are known to exist in the
dermis and lamina propria7, only a single subset has been
described in healthy epidermis called Langerhans cells (LC). LCs
form an interconnected network and are known to bind HIV via
the C-type lectin receptor (CLR) langerin8,9. LCs are reported to
be involved in sexual transmission of HIV but their role needs to
be more clearly defined1–3,8–10.
As APCs, LCs express high levels of CD45 and HLA-DR on
their surface as well as CD1a3,9 and the HIV binding CLR lan-
gerin2. They express low levels of the integrin CD11c, which is
highly expressed by murine conventional DCs and human cDC2,
and do not express the HIV binding CLRs Dendritic Cell-Specific
Intercellular adhesion molecule-3-Grabbing Nonintegrin (DC-
SIGN) or mannose receptor (MR). These cells are believed to be
the only MNP found within healthy epidermis. In inflamed epi-
dermis an additional MNP subset has been described referred to
as Inflammatory Dendritic Epidermal Cell (IDEC), which can be
discerned from LCs by their high expression of CD11c and
MR11–14.
Recently we found that trypsin, which is the most common
enzyme used to isolate LCs from the epidermis, cleaved CD11c as
well as multiple pathogen binding receptors and the HIV entry
receptor CD415. This may have affected identification of epi-
dermal MNPs and their HIV transmission capacity. In this study,
using our optimised MNP isolation protocols, we identify a subset
of MNPs in healthy epidermis, in addition to LCs. These cells
express high CD11c and MR which we refer to as epidermal
CD11c+ DCs. Importantly, they are enriched in anogenital epi-
dermis where they interact with HIV preferentially to LCs. These
cells also express higher amounts of CCR5 on their surface
compared to LCs, are more permissive for infection with HIV and
more efficient at transferring HIV to CD4 T cells. We also
identify a population of cells that are phenotypically similar to
LCs but express lower levels of CD45, HLA-DR and CD33.
However, they do not stimulate T cell proliferation or act as HIV
target cells. We refer to these cells as epidermal CD33low cells.
Results
Three subsets of mononuclear phagocytes in healthy epidermis.
Previously we have optimised skin enzymatic digestion protocols
to liberate MNPs with an immature phenotype and minimal
surface receptor cleavage. Critically, we found that trypsin cleaved
many MNP defining markers including CD1c and CD11c
whereas collagenase did not15. Using this method we digested
fresh healthy abdominal epidermal sheets with collagenase and
identified three CD45+/HLA-DR+/CD3−/CD19− cell popula-
tions using flow cytometry (Fig. 1a). LCs could be discerned by
their high surface expression of CD1a, langerin and CD33,
low CD11c expression and absence of MR expression. A second
CD1a+langerin+CD11clowMR− cell type could be distinguished
from LCs by their much lower surface expression of CD33 as well
as lower levels of CD45, HLA-DR and CD1a. We refer to these
cells as epidermal CD33low cells. Finally, we observed a
CD11chigh cell that also expressed MR, higher levels of HLA-DR
and CD1c and slightly lower levels of CD1a than LCs and in most
cases did not express langerin. We refer to these as epidermal
CD11c+ DCs. All three epidermal populations did not express
CD14 or CLEC9A demonstrating that they were not con-
taminating dermal cDC1 or monocyte-derived macrophages. We
then investigated how the epidermal MNP subsets related to
dermal MNPs using our gating strategy that identifies all known
human dermal MNP subsets15 (Supplementary Fig. 1a). Inter-
estingly, we found that epidermal CD11c+ DCs aligned closely to
dermal cDC2. We then compared trypsin and collagenase
digestion and confirmed that CD11c+ cells were not detected
when using trypsin, which cleaves CD11c, to digest epidermis
(Fig. 1b).
We next used flow cytometry to determine the relative
abundance of each cell type within the CD45+HLA-DR+
population in abdominal epidermis using 75 healthy donors
(Fig. 1c). Although there was some donor variability, LCs were
the most abundant cell type followed by epidermal CD11c+ DCs
and then epidermal CD33low cells.
We next used RNAseq to compare the transcriptional profiles
of epidermal CD11c+ DCs and CD33low cells to all known
subsets of human skin MNPs (Fig. 2). Consistent with the flow
cytometry profiling (Supplementary Fig. 1a) we found that
epidermal CD11c+ DCs were transcriptionally very similar to
both known subsets of dermal cDC2 and could not be
distinguished by principle component analysis. In contrast,
CD33low cells were transcriptionally very similar to LCs (Fig. 2a).
Heatmaps constructed using the top 40 differential genes between
subsets showed similar clustering (Fig. 2b), which was confirmed
by QPCR (Supplementary Fig. 2).
We next assessed the presence of epidermal MNPs in situ.
Firstly, we carried out intracellular staining and assessed the effect
that this had on identifying each population by flow cytometry
(Supplementary Fig. 1b). Although, we could still clearly discern a
discrete CD11c+ cell population, we were unable to visualise a
CD33low population as all HLA-DR+CD1a+ epidermal cells
expressed CD33 at equal levels intracellularly. We next stained
abdominal tissue blocks with CD1c, CD11c, MR and langerin and
confirmed using immunofluorescence microscopy that in contrast
to LCs, epidermal CD11c+ DCs were bright for CD11c and
CD1c, expressed low levels of MR and did not express langerin
(Fig. 3a). Although both populations could be clearly visualised,
epidermal CD11c+ DCs were almost always observed close to the
basement membrane whereas LCs were dispersed throughout the
epithelium (Fig. 3b). Furthermore, we observed that epidermal
CD11c+ cells clustered in distinct regions, which were con-
comitant with a decrease in LC density.
Finally, we FACS-sorted each epidermal MNP population, as
well as dermal CD11c+ cDC2, and examined their morphology
using Giemsa staining (Fig. 3c). Each epidermal population was
distinct but possessed morphological characteristics of DCs and
not lymphocytes, macrophages or mast cells16. LCs could be
discerned by their dendrite structures; epidermal CD33low cells
were the smallest subset and epidermal CD11c+ DCs were similar
to dermal CD11c+ cDC2.
Epidermal mononuclear phagocyte pathogen receptor
expression. A defining feature of MNPs is their ability to capture
pathogens via an array of lectin receptors (CLRs and Siglecs)
expressed on their surface17,18. Using the appropriate blend of
collagenase to liberate cells from healthy abdominal tissue15 we
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10697-w
2 NATURE COMMUNICATIONS |         (2019) 10:2759 | https://doi.org/10.1038/s41467-019-10697-w |www.nature.com/naturecommunications
next defined the lectin surface expression profiles of each epi-
dermal MNP subset using flow cytometry and also compared
them to dermal cDC2. Furthermore, as LCs have been shown to
be infected by HIV, we also measured the surface expression of
the HIV entry receptors CD4, CCR5 and CXCR4 (Table 1 and
Supplementary Fig. 3). LCs expressed high levels of langerin,
CLEC5A and DCIR, moderate levels of DEC205, Siglec-3 (CD33)
and Siglec-9, low levels of CD4 and CCR5, and did not express
MR, DC-SIGN or CXCR4. Other than expressing lower levels of
Siglec-3 (CD33), epidermal CD33low cells showed an almost
identical pattern of lectin receptor expression to LCs. However
they did not express any of the HIV entry receptors CD4, CCR5
or CXCR4. Epidermal CD11c+ DCs expressed all the lectins
expressed by LCs except for langerin. In addition, and distinct
from LCs, CD11c+ DCs expressed CLEC4M (L-SIGN),
CLEC10A, CLEC12A and MR as well as Siglec-5 and much
higher levels of Siglec-9. Consistent with their transcriptional
profiles (Fig. 2) this was a similar pattern of surface expression to
dermal cDC2 but the two populations did differ in that dermal
cDC2 expressed low levels of CLEC8A, Siglec-1, Siglec-6 and
Siglec-16 and much higher levels of MR. Importantly, we also
observed that epidermal CD11c+ DCs expressed much higher
levels of the HIV entry receptor CCR5 than any other MNP
(including dermal cDC2).
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Fig. 1 Definition of distinct human epidermal mononuclear phagocytes by flow cytometry. Mononuclear phagocytes were liberated from human epidermis
using trypsin or Type IV collagenase. a Flow cytometry was used to define three subsets of CD3−/CD19epidermal MNPs from collagenase digested tissue
(i) Langerhans cells (green) were defined as HLA-DRintermediate, CD1avery high, langerinhigh, CD33+, CD11c−, MR− (ii) epidermal CD11c+ DCs (blue) were
defined as HLA-DRhigh, CD1a+, langerinlow, CD11c+, MR+ (iii) epidermal CD33low cells (black) were defined as HLA-DRlow, CD1a+, langerinhigh, CD33low,
CD11c−, MR−. Representative data of 75 individual donors is shown. b CD11c expression was compared on cells derived from trypsin and collagenase
digestion. The blue circle indicates the CD11c+ cells detected in collagenase digested tissue that are not observed in trypsin digested tissue. Representative
data of five individual donors is shown. c The relative proportion of each subset CD45+ HLA-DR+ gate after collagenase digestion was determined and is
shown as a mean ± the standard deviation with each dot representing an individual donor. Statistics were generated using the Mann–Whitney test. *p <
0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (n= 75)
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Fig. 2 Transcriptional profiling of epidermal and dermal human mononuclear phagocytes. Epidermal LCs, CD11c+DCs and CD33low cells and dermal cDC1,
cDC2 (langerin+ and −), monocyte derived macrophages and tissue resident macrophages were FACS sorted from 4 individual donors. RNA was amplified
and RNAseq carried out. a A tSNE plot highlights similarities between the cell subsets. bModerated linear models were used to identify genes whose high
or low expression characterised each subset. Heat maps display expression values of the top 40 genes that uniquely identify; CD33low MNPs and LCs;
cDC2 and epidermal CD11c; cDC1; and monocyte-derived macrophages and tissue resident Macrophages
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Mononuclear phagocyte functional characterisation. In
response to pathogen detection MNPs undergo a process of
maturation whereby they secrete a specific range of cytokines and
upregulate molecules involved T cell binding (CD54) and costi-
mulatory molecules (CD80, CD83 and CD86) which allows them
to activate T cells to undergo proliferation7. We therefore used a
cytometric bead array assay to define the cytokines that each
epidermal subset and dermal cDC2 secreted in response to a TLR
agonist cocktail (Fig. 4a). We also measured CD54 and co-
stimulatory molecule surface expression on each epidermal subset
(Fig. 4b) and carried out T cell alloproliferation assays (Fig. 4c).
We found that each subset had a unique cytokine expression
profile. LCs produced IL-8 and low levels of IL-1α and TNF
whereas epidermal CD33low cells did not secrete any cytokines to
detectable levels. Epidermal CD11c+ DCs and dermal
DC2 showed a similar cytokine expression profile and produced
IL-1β, IL-6, IL-8, IL-10 and TNF. However, notably, epidermal
CD11c+ DCs secreted higher levels in all cases which reached
statistical significance for IL-6, IL-8 and IL-10. cDC2 but not
epidermal CD11c+ DCs produced IL-1. Consistent with their lack
of cytokine secretion we also found that epidermal CD33low cells
expressed lower levels of co-stimulatory molecules on their sur-
face and were poor inducers of naïve T cell proliferation. Epi-
dermal CD11c+ DCs and LCs expressed CD83 and CD86 at
similar levels and were efficient at inducing T cell proliferation.
However, epidermal CD11c+ DCs and dermal cDC2 expressed
significantly higher levels of CD80 compared to LCs and epi-
dermal CD11c+ DCs expressed significantly higher levels CD54
then all other cell types.
Enrichment of CD11c DCs in anogenital tissues and langerin.
As epidermal CD11c+ DCs derived from abdominal skin
expressed higher levels of the HIV entry receptor CCR5 (Table 1
and Supplementary Fig. 3), we hypothesised that they would be
preferential targets for HIV infection compared to the other two
epidermal MNP subtypes. We therefore obtained human ano-
genital tissues containing a stratified squamous epithelium that
HIV may encounter during sexual transmission (labia, vagina,
foreskin, glans penis, fossa navicularis, anal canal and perineum)
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Fig. 3 Visualisation of CD11c+ dendritic cells in situ and morphological staining of epidermal MNPs. a, b Human abdominal tissue was sectioned
and stained for HLA-DR, CD11c, CD1c, MR and langerin for fluorescence microscopy. All images representative of at least 3 different donors. a Epidermal
CD11c+ DCs could be discerned from LCs by their expression of MR, brighter expression of CD1c and CD11c and lack of langerin expression. b Epidermal
CD11c+ DCs (white arrows) could be discerned from LCs (red arrows) in situ as HLA-DR+, CD11cbright cells and were almost always situated close to the
basement membrane. c Epidermal sheets were digested with collagenase Type IV and each epidermal HLA-DR+CD45+MNP population was FACS sorted
and a Giemsa stain carried out for morphological examination
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and compared the relative proportions of respective epidermal
MNP subsets in each tissue by flow cytometry (Fig. 5a). We found
that epidermal CD11c+ DCs were enriched in anogenital tissues
compared to abdomen. We then confirmed our ex vivo data by
showing that the relative proportions of LCs and epidermal
CD11c+ DCs were the same in situ in inner foreskin by flores-
cence microscopy (Fig. 5b). Partly, to exclude the possibility that
the epidermal CD11c+ DCs were contaminating lamina propria
CD11c+ DCs, we stained for CD1a on CD11c+ cells derived from
both tissues as, unlike dermis, CD1a is not expressed in the
lamina propria (Supplemental Fig. 1c). In contrast to lamina
propria at least 50% of vaginal epithelial CD11c+ cells expressed
CD1a. Relevant to HIV transmission, we confirmed that epi-
dermal CD11c+ DCs expressed higher amounts of CCR5 in these
tissues compared to LCs and CD33low cells (Fig. 5c). Finally, in
contrast to abdominal tissue, between 50 and 80% of anogenital
CD11c+ DCs expressed langerin on their surface (Fig. 5d).
Epidermal CD11c DCs preferentially interact with HIV in situ.
We next determined if epidermal CD11c+ DCs interacted with
HIV in situ. To this end we topically applied the lab-adapted
HIV-1 BaL strain as well as the transmitted/founder strain HIV-1
Z3678M19 to fresh inner foreskin explants for 2 h and used
RNAscope in situ hybridization technology to investigate if epi-
dermal CD11c+ DCs interacted with the virus. The technology
uses probes and a detection system that can be developed with
fluorescent chromogens and can detect HIV with single virion
sensitivity. This method overcomes the high background staining
observed with antibodies to detect HIV and lower infectivity
when using fluorescently labelled virions20. Unlike abdominal
tissue where almost all epidermal CD11c+ DCs were present in
the basal layer close to the basement membrane (Fig. 4b), in inner
foreskin CD11c+ DCs could be visualised throughout the epi-
thelial layer (Fig. 6a) similar to LCs (Fig. 6b). In tissue infected
with both virus strains, epidermal CD11c+ DCs were visualised
appearing to contain virion RNA within them (Fig. 6c) and could
sometimes be seen close to the epithelial surface appearing to
extend out dendritic processes to contact virions (Fig. 6c).
Additional images of CD11c+ DCs interacting with HIV-1BaL
and HIV1Z3678B in three additional independent donors are
shown in Supplemental Fig. 4a, b. Consistent with the published
literature2,3 we also observed some LCs containing HIV (Fig. 6d),
which are reported to rapidly migrate out of the epidermis after
infection. Finally, we quantified the relative amount of HIV that
could be detected localising to both LCs and epidermal CD11c+
DCs in situ using transmitted/founder strain Z3678M. We found
that there was significantly more HIV-1 associated with epi-
dermal CD11c+ DCs compared to LCs (Fig. 6e). As controls,
RNAscope was performed on mock tissue using HIV specific
probes (Supplemental Fig. 4c), and HIV treated tissue using the
bacterial dapB specific probe as a negative probe (Supplemental
Fig. 4d). In both cases the incidence of false positive signals was
negligible.
HIV infection of CD11c DCs and transfer to CD4 T cells. As
we observed that epidermal CD11c+ DCs appeared to take up
HIV in situ (Fig. 6d) and that they expressed high CCR5 levels
(Fig. 5b), we next assessed their ability to take up and become
infected by HIV-1 and then transfer the virus to CD4 T cells
ex vivo. To this end we sorted epidermal CD11c+ DCs, CD33low
cells and LCs as well as dermal cDC2 from abdominal skin and
then infected them with the lab-adapted HIV-1 BaL strain and/or
the transmitted/founder strain HIV-1 Z3678M19.
Firstly we used flow cytometry to directly measure the amount
of HIV RNA (PrimeFlow) and p24 protein contained within
epidermal CD11c+ DCs and LCs after 2 and 96 h of HIV
exposure using HIV-1Z3678M (Fig. 7a). We found that epidermal
CD11c+ DCs contained higher levels of HIV RNA and p24 than
Table 1 Pathogen binding receptor surface expression profiles of epidermal MNPs
Marker Collagenase blend Epidermal LCs Epidermal CD33low cell Epidermal CD11c+ DC Dermal cDC2
CD4 Type IV + − ++ ++
CCR5 Blend F + − +++ +
CXCR4 Type IV − − − −
Clec4A (DCIR) Blend F ++++ +++ +++++ +++++
ClecC4D Blend F − − − −
Clec4E Blend F + ++ +++ +++
Clec4K (langerin) Blend F +++++ +++++ − −
Clec4L (DC-SIGN) Blend F − − − −
Clec4M (L-SIGN) Blend F − − ++ ++
Clec5A Blend F +++++ +++ +++++ +++++
Clec5B Blend F − − − −
Clec5C Blend F − − − −
Clec6A (Dectin2) Blend F − − − −
Clec8A Blend F − − − +
Clec8A Blend F − − − −
Clec10A Blend F − − ++ ++
Clec12A Blend F − − +++ +++
Clec13B (DEC205) Blend F ++ + + +
Clec13D (MR) Blend F − − ++ ++++
Clec14A Blend F − − − −
Siglec-1 Blend F − − − +
Siglec-3 (CD33) Blend F +++++ + +++++ +++
Siglec-5 Blend F − − + +
Siglec-6 Blend F − − − +
Siglec-9 Blend F ++ + ++++ ++++
Siglec-16 Blend F − − − +
Ex vivo epidermal MNPs and dermal cDC2 were isolated from human skin using either Blend F or Type IV collagenase and the surface expression was determined for a range of pathogen binding
receptors and HIV entry receptors by flow cytometry. The table shows the mean surface expression (MFI) of each surface marker from five independent donors. −MFI < 100, +MFI 100− 499, ++MFI
500− 999, +++MFI 1000− 4999, ++++5000− 9999, +++++MFI≥ 10,000. Representative histograms for each marker on each cell type are shown in Supplementary Fig. 2.
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LCs after 2 h indicating that they are more efficient at HIV
uptake. We also found that they contained higher levels of p24
than LCs at 96 h indicating that they support higher levels of
productive infection.
To confirm that these cells were productively infected and
secreted infectious virus we collected supernatants from cells
infected with both HIV-1BaL and HIV-1Z3678M for 96 h and
cultured them with TZMBL1 CD4 T cells and measured their
infectivity (Fig. 7b). As expected TZMBL1 CD4 T cells cultured
with HIV-1 BaL infected cell supernatants derived from
epidermal CD11c+ DCs became significantly more infected than
those cultured with supernatants derived from LCs, CD33low cells
and cDC2. Similarly, TZMBL1 CD4 T cells cultured with HIV-1
Z3678M derived from epidermal CD11c+ DCs became signifi-
cantly more infected than those cultured with supernatants
derived from LCs.
Next, we measured the ability of each cell type to transfer the
virus to CD4 T cells using our MNP-T cell transfer assay9,21–23
and optimised MNP culture conditions15 (Fig. 8a). Consistent
with their lack of CD4 and CCR5 expression and low levels of
infectivity, CD33low cells were unable to transfer the virus to CD4
T cells. Consistent with their enhanced ability to take up and
become infected with HIVBal, epidermal CD11c+ DCs were the
most efficient cells at transferring the virus to CD4 T cells after
96 h. Similar results were observed using HIVZ3678M. In order to
rule out the unlikely possibility that transfer of HIV from
epidermal CD11c+ DCs to CD4 cells was a result of virus retained
on the cell surface, we used our two phase transfer assay and
showed that transfer of HIVBal to CD4 T cells by epidermal
CD11c+ DCs declined rapidly with time between 2 and 24 h
before a second phase transfer began to occur after 72 h as a result
of de novo produced virions (Fig. 8b). Furthermore, to show that
transfer of HIV-1 to CD4 T cells is dependent on them becoming
productively infected via gp120/CCR5 mediated entry, we pre-
treated epidermal CD11c+ DCs and LCs with the CCR5 blocking
drug maraviroc and showed that this completely blocked their
ability to mediate transfer of HIVBal to CD4 T cells after 96 h
(Fig. 8c).
Discussion
We report here the observation of three human CD45+ HLA-DR+
epidermal subsets in human abdominal and anogenital epidermis,
two of which have not been previously reported in healthy tissue to
the best of our knowledge. We refer to these subsets as LCs, epi-
dermal CD11c+ DCs and epidermal CD33low cells. We tran-
scriptionally profiled each cell type and then functionally
characterised them in terms of their pathogen binding receptor
expression, cytokine secretion profiles, costimulatory marker
expression and ability to induce T cell proliferation. Critically, we
showed that epidermal CD11c+ DCs are able to interact with both
lab-adapted and transmitted/founder HIV strains at the anogenital
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epithelial surface and take up the virus preferentially to LCs. Fur-
thermore they are most efficient at HIV uptake, support the highest
levels of infection and are the most efficient at transferring HIV to
CD4 T cells, after de novo infection.
LCs have previously been considered to be the only MNP
found within healthy human epidermis. However, in almost all
published reports trypsin is used to liberate these cells from tissue
and we recently demonstrated that trypsin cleaves several key
markers used to discriminate MNPs such as CD11c and CD1c
and many pathogen binding receptors such as the key HIV
binding receptor CD49,14. We therefore digested healthy human
abdominal epidermis with collagenase and identified CD11c+
DCs. Unlike LC, these cells did not express langerin in most cases
and they also expressed a greater array of pathogen binding lectin
receptors. Although these cells were less abundant than LCs they
were present in easily identifiable proportions in almost every
donor we examined (n= 75). We found that epidermal CD11c+
DCs were almost identical to dermal cDC2 by transcriptional
profiling and showed similar cell surface marker expression17.
Furthermore, they morphologically resembled dermal cDC2 and,
in abdominal tissue, these cells were usually found deep in the
epidermis close to but above the basement membrane i.e. they
were not dermal contaminates. In inflamed epidermis CD11c+
IDECs have been described which can be further discerned from
LCs by their expression of MR11–14. We confirm here that our
epidermal CD11c+ DCs also express MR but at much lower levels
than dermal cDC2. We therefore hypothesise that the epidermal
CD11c+ DCs we observe here (and probably IDECs) are cDC2
CD
4 
AP
C
CCR5 PE
Live, HLA-DR+,
CD45+ singlets
Langerin vioblue
CD
1a
 B
V5
10
GlansAbdomen
d
36.4%10.7%
0
20
40
60
80
100Live, HLA-DR+, CD45+ singlets,
CD11c+ DCs
Langerhans cell CD11c+ DCsCD33low cell
0
20
40
60
80
Inner foreskin
0
20
40
60
80
100
%
 C
D4
5+
 H
LA
DR
+
p = 0.044
Skin Type II mucosae
p = 0.0018
p = 0.0008
p = 0.0368
p = 0.0023
p = 0.0003
%
 L
an
ge
rin
 +
105
104
103
102
0
105
104
103
0
–103 103 104 1050 103 104 1050
103 104 1050
103
104
105
Ab
do
me
n
La
bia
Ou
ter
for
es
kin In
ne
r
for
es
kin
Gla
ns 
pe
nis
Pe
rin
eu
m
Va
gin
a
Fo
ssa
na
vic
ula
ris
An
al 
ca
na
l
CD
11
c+  
DC
s
0
Ce
lls
/m
m
2
LC
s
Ab
do
me
n
La
bia
Inn
er 
for
es
kin
Ou
ter
 fo
res
kin
Gla
ns
Pe
rin
eu
m
Va
gin
a
Fo
ssa
 na
vic
ula
ris
An
al 
ca
na
l
a b
c
Fig. 5 Phenotypic analysis of epidermal mononuclear phagocytes in anogenital tissues. a Mononuclear phagocytes were liberated from anogenital
epidermis and using Type IV collagenase and the relative proportion of each subset within the CD45+HLA-DR+ gate was determined and is shown as a
mean ± the standard deviation with each dot representing an individual donor. Statistics for subsets in each tissue were generated using the Kruskal–Wallis
test (Abdominal skin= 75, Labia= 6, Outer Foreskin= 9, Inner Foreskin= 5, Glans Penis= 11, Perineum= 3, Vagina= 5, Fossa Navicularis= 4, Anal
Canal= 3). A pie chart summarising the average proportions of each epidermal subset in each anogenital tissue is shown underneath. b Using fluorescent
microscopy we outlined the epidermis of inner foreskin (using pan-keratin stain as a reference) and calculated the density of CD11c+ DCs and LCs within
this compartment (n= 7). c Representative flow cytometry data using inner foreskin showing that CCR5 is expressed more highly by epidermal CD11c+ DC
than LCs or epidermal CD33low cells. Representative of n= 5 donors. d The percentage of epidermal CD11c+ DCs that express langerin in abdominal and
anogenital tissues is shown. Left: Representative data from abdomen and glans penis. Right: data for each tissue is shown as a mean ± the standard
deviation with each dot representing an individual donor. Donor numbers for each tissue are as described in part A, except for vaginal tissue and fossa
navicularis where five and three donors were analysed, respectively
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10697-w
8 NATURE COMMUNICATIONS |         (2019) 10:2759 | https://doi.org/10.1038/s41467-019-10697-w |www.nature.com/naturecommunications
DAPI CD11c HIV RNA
Langerin
10 um
CD11c
HIV
RNA
Langerin
50 um
C
D
11
c 
D
A
P
I
C
D
11
c
DAPI CD11c CD11c
Donor 1
Donor 2
0
LCs CD11c+
100
200
300
D
is
ta
nc
e 
fr
om
 B
M
 (
μm
)
50 um 10 um
LCs
CD11c
DCs 
10 um
40 um
HIV RNA
CD11c
HIV RNA
Langerin
Donor 1
(HIV-1 BaL)
40 um
HIV RNA
CD11c
HIV RNA
LangerinDonor 2
(HIV-1 BaL)
20 um
HIV RNA
Langerin
HIV RNA
CD11c
Donor 2
(HIV-1 Z3678 M)
DAPI CD11c HIV RNA
Langerin DIC
30 um
XY XZ
HIV RNA
CD11c
HIV RNA
Langerin
Donor 1
(HIV-1 Z3678 M)
10 um
10 um
10 um
2 um
5 um
2 um
A
re
a 
of
 H
IV
 lo
ca
lis
in
g
to
 c
el
ls
 (
um
2 )
80
60
40
20
0
a b
c
d
e
YZ
XY XZ YZ
Fig. 6 Visualisation of anogenital CD11c+ dendritic cells in situ and their interactions with HIV. Human foreskin explants were treated with lab-adapted
HIVBaL or transmitted/founder HIVZ3678M or PBS (mock) for 2–3 h before being fixed and paraffin embedded. The tissue was then sectioned and probed for
HIV RNA using RNAscope coupled with immunofluorescent staining for CD11c and langerin. Epidermal CD11c+ cells are shown with white arrows and LCs
with yellow arrows. Representative images of 5 (HIVBaL) or 3 (HIVZ3678M) independent donors are shown (see Supplemental Fig. 3a for images from
additional donors). a In healthy inner foreskin CD11c+ cells were visualised throughout the epithelial layer. The broken line indicates the basement
membrane. b In 10 donors we manually outlined LCs and epidermal CD11c+DCs and calculated their average distance from the basement membrane using
the ‘distance map’ plug in ImageJ. c CD11c+ DCs were observed interacting with HIVBaL and HIVZ3678M (top panels) at the epidermal surface or deeper in
the epidermis containing HIV virions (bottom panels). For transmitted founder images Z- stacks were performed with 0.1 micron Z spacing and XY, XZ and
YZ projections were generated. Scale bar on the dashed inset image is 1 um. d CD11c− langerin+ Langerhans cells could also be detected containing HIV
virions. e For donors infected with transmitted/founder HIVZ3678M, the area of HIV overlap with epidermal CD11c+ cells and LCs was calculated by
measuring the area of ‘intersection’ of each cell type with HIV. 3 sections were measured from three independent donors (nine sections in total). The total
area of epidermis measured for each donor was between 23–43mm2 (54–102 × 20 fields) (p= 0.0039) two-tailed Mann–Whitney Test
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10697-w ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2759 | https://doi.org/10.1038/s41467-019-10697-w |www.nature.com/naturecommunications 9
that have migrated into the lower epidermis from the dermis.
This hypothesis is strengthened by the observation that a small
proportion of the population express langerin, similar to dermal
cDC224. However it should be noted that the two cell types were
not identical as, in contrast to epidermal CD11c+ DCs, cDC2
expressed higher levels of CLEC8A, Siglec-1 and lower levels of
Siglec-16 on their surface, secreted IL-1α and significantly lower
levels of IL-6, IL-8 and IL-10, and were weaker inducers of T cell
proliferation.
LCs have been shown to bind HIV via their CLR langerin and
can also become productively infected due their expression of the
HIV entry receptors CD4 and CCR59,25. However the role these
cells play in sexual transmission is unclear with some groups
arguing they act as a natural barrier to HIV infection by rapidly
degrading the virus in Birbeck granules8,10 and others arguing
that they directly transfer the virus to CD4 T cells2–4,9,26. In order
to overcome the poor specificity of HIV antibodies and difficulties
in distinguishing fluorescently labelled HIV from autofluorescent
structures, we employed recently developed RNAscope technol-
ogy. This uses florescent nucleotide probes that bind the HIV
genome followed by signal amplification and detected the virus
with single virion sensitivity20. This technique enabled us to show
that epidermal CD11c+ DCs may play a key role in transmission
of HIV. Unlike abdominal epidermis, in human inner foreskin we
observed these cells throughout the epithelial layer, as opposed to
being situated close to the basement membrane. Critically, within
2 h of topical application of purified lab-adapted or transmitted/
founder HIV strains we observed CD11c+ DCs at the epithelial
surface appearing to extend processes superficially to capture the
virus and CD11c+ HIV containing cells throughout the epithelial
layer. Furthermore, more HIV RNA was localised to these cells
than LCs in situ. Correspondingly, they also express higher levels
of the HIV entry receptor CCR5 as well as the T cell adhesion
molecule CD54, the costimulatory molecule CD80 than LCs.
They were also much more efficient at HIV uptake than LCs,
supported higher levels of productive infection and transferred
the virus to CD4 T cells with much greater efficiency. We have
previously shown that both monocyte-derived DCs21,23 and LCs9
are able to capture HIV and then transfer the virus to CD4 T cells
in two successive phases. The first phase of transfer is not
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dependent of productive infection, but rather on CLR mediated
endocytic uptake, and occurs within 2 h and then declines rapidly
with time until 24 h post exposure when no transfer to CD4
T cells is observed. The second phase of transfer occurs as a result
of CD4/CCR5 mediated productive infection and begins to occur
within 72 h of infection and increases with time as newly formed
virions bud off from the plasma membrane. Therefore, in order to
shown that the more efficient capacity of our epidermal CD11c+
DCs to transfer HIV to CD4 T cells compared to LCs was as
result of their increased capacity to become productively infected
(correlating with higher CCR5 expression levels), and not as a
result of virus being stuck to the cells surface, we performed our 2
phase transfer assay. As expected, similar to monocyte-derived
DCs and LC, transfer of the virus from epidermal CD11c+ DCs
declined rapidly with time over 24 h before a second wave of
transfer was observed from 72 to 96 h. To further confirm that the
enhanced transfer capacity of epidermal CD11c+ DCs was due to
their higher CCR5 expression we showed that the CCR5 blocking
drug maraviroc blocked the ability of these cells to mediate
transfer. Future studies are required to characterise the receptors
involved in first phase transfer, likely to be CLRs as with MDDCs
(DC-SIGN) and LCs (langerin).
In similar studies to ours, vagina and foreskin LCs have been
shown to behave similarly. Using human vaginal explants Hladik
and colleagues showed that LCs take up HIV and form clusters
with T cells and transfer the virus3. Similarly, using human
foreskin explants, Ganor and colleagues showed that LCs redis-
tribute within 1 h of HIV exposure, capture the virus and then
transfer it CD4 T cells2. In addition Patterson and colleagues
showed that HIV infection of foreskin explants after topical
application was predominantly in CD4 T cells and LCs at the base
of the epithelial layer4. However, these studies identified LCs
using only CD1a and/or langerin. Our data indicates that this is
not sufficient to discriminate LCs from epidermal CD11c+ DCs
in anogenital epithelium where up to 80% express langerin.
Furthermore, we find that CD11c+ DCs are significantly enriched
in the epidermis of anogenital tissues. It is therefore probable that
these previous studies were observing a mixed population of
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Representative plots are shown
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epidermal CD11c+ DCs and LCs. This becomes especially
apparent as we observe epidermal CD11c+ DCs in foreskin
capturing HIV at the surface in an identical manner to the
CD1a+/langerin+ cells observed by Ganor and colleagues2. In our
hands, both epidermal CD11c+ DCs and LCs contained HIV
virions in situ and more HIV is localised to epidermal CD11c+
DCs than LCs. Finally Pena-Cruz and colleagues27 have recently
reported a similar type of HIV binding epidermal DC in vaginal
epithelium. However they did not characterise these cells with
same phenotypic and functional scrutiny (e.g. CD11c expression)
as we report here and further characterisation is required to
determine whether it is the vaginal equivalent of the CD11c+ DCs
we describe here throughout the anogenital epithelium.
We also identified a third population of CD45lo HLA-DRlo
cells in the epidermis which, with the exception of their low
expressed of CD33 (Siglec-3), were phenotypically very similar to
LCs in their surface marker expression. We found that they were
transcriptionally very similar to LCs however they were smaller,
possessed fewer dendrites, did not secrete cytokines and were very
weak inducers of T cell proliferation. Their precise relationship to
LCs is unclear.
LCs are known to self-replenish locally within skin28 and
repopulate after inflammation in two waves, the first wave consist
of a transient population that are derived from circulating
monocytes and the second establish long-term LCs derived from
precursors of an unknown origin29. Whether the CD33low cells
we describe here represent a local or recruited precursor LC
population requires further exploration in a future study.
In conclusion we have defined an epidermal HIV target cell
that may play a critical role in sexual transmission of HIV. The
role in viral transmission or immune clearance in epithelial tis-
sues may extend to pathogens other than HIV and requires fur-
ther investigation. In the context of viral transmission, LCs have
been shown to relay HSV to dermal MNPs30 and it will now be
important to examine to role of epidermal CD11c+ DCs in this
process for both HSV and HIV. The location of CD11c+ DCs in
the epithelium also provides the opportunity for early interven-
tion to inhibit transmission.
Methods
Sources of tissues and ethical approval. This study was approved by the Wes-
tern Sydney Local Area Health District (WSLHD) Human Research Ethics Com-
mittee (HREC); reference number (4192) AU RED HREC/15 WMEAD/11.
Healthy human abdominal and genital tissues were obtained within 30 min of
surgery from a range of patients undergoing plastic surgery (abdomen, labia,
vagina), circumcision (foreskin), gender reassignment (glans penis, fossa navicu-
laris) or colorectal surgery (anal canal, perineum) with written consent from all
donors.
Preparation of high-titre purified HIV-1 virus stocks. Titres of 108–109 50%
tissue culture infective doses (TCID50)/mL of either the laboratory adapted HIVBaL
strain, or the HIVZ3678M transmitted founder strain were produced by
transfection22,26,31–34. 16 million HEK 293 T cells were seeded per T150 flask
(Becton Dickinson,Franklin Lakes,New Jersey, USA). The next day, cells were
transfected with 80 µg of plasmid DNA pWT/BaL (NIH AIDS Research and
Reference Reagent Program, contributed by Dr. Bryan R. Cullen) or pHIVZ3678MTF
(Eric Hunter, Genbank accession number: KR820393), and the following all from
Sigma-Aldrich, 128 uL 2M CaCl2, 1 mL (1 mMTris,0.1 mM EDTA, pH8.0), 1 mL
Hepes-buffered saline (280 mM NaCl, 50 mM HEPES, pH7.1), 10 μL 0.15M
Na2HPO4 (pH 7.1) and 15 mLDulbecco Modified Eagle Medium (DMEM, Lonza)
with 10% Foetal Calf Serum (FCS, Lonza). The next day, media was replaced with
DMEM with 10% FCS. After 2 days, media was collected into 50 mL falcon tubes,
centrifuged at 1600 g for 20 min and supernatant was collected. Supernatant was
concentrated to 1 mL by centrifuging in 300,000 molecular weight cut-off filters
(Vivaspin 20, Sartorius, Göttingen, Germany) at 3000 g. Purified high titre HIV-
1BaL stocks in the order of 2 × 109 TCID50/mL were generated by infection of
SUPT1.CCR5-CL.30 cells (Human Non-Hodgkin’s T lymphocyte Lymphoma,
contributed by Prof. James Hoxie at the University of PA). CD45+ MVs were
depleted from supernatant using CD45 magnetic beads (Miltenyi Biotech). Virus
(18 mL) was incubated at room temperature with 2 mL microbeads for 2 h before
adding to the top of a LS column. CD45 depleted virus that flowed through the
column as well as non-depleted supernatants for HIVZ3678M were concentrated
further by ultracentrifugation with 1 mL under-layed 20% sucrose cushion and
centrifuged at 100,000 × g (Beckman Optima XL-100 K Ultracentrifuge with 70Ti
rotor) at 4 °C for 90 min. The 50% tissue culture infectious dose (TCID50) values
were generated in TZM-BL cells (NIH AIDS Research and Reference Reagent
Program, contributed by John Kappes and Xiaoyun Wu) measured by LTR β-
galactosidase reporter gene expression after a single round of infection. Endotoxin
levels were below the detection limit (Limulus amebocyte lysate assay; Sigma) and
were negative for tumor necrosis factor alpha (TNF-α), IFN-α, and IFN-β by
enzyme-linked immunosorbent assay (ELISA).
Tissue processing. MNP were isolated from abdominal tissue using our optimised
collagenase based digestion process15. Skin was collected immediately after surgery
skin was stretched out and sectioned using a skin graft knife (Swann-Morton,
Sheffield, United Kingdom) and the resulting skin grafts passed through a skin
graft mesher (Zimmer Bionet, Warsaw, IN, USA). The meshed skin was placed in
RPMI1640 (Lonza) with 0.14 U/ml dispase (neutral protease, Worthigton Indus-
tries, Columbus,OH, USA) and 50 μg/mL Gentamicin (Sigma-Aldrich, St Louis,
MO, USA) and rotated at 4 °C overnight. The skin was then washed in PBS
and split into dermis and epidermis using fine forceps. Dermal tissue was cut into
1–2 mm pieces using a scalpel. Dermal and epidermal tissue was then incubated
separately in media containing 100 U/ml DNase I (Worthington Industries) and
200 U/ml collagenase Type IV (Worthington) at 37 °C for 120 min in a rotator. The
cells were then separated from undigested dermal and epidermal tissue using a tea
strainer. The supernatants were then passed through a 100 μm cell strainer
(Greiner Bio-One, Monroe, NC, USA) and the cells pelleted. The cell pellet was
then passed again through a 100 μm cell strainer, and incubated in MACS wash
(PBS (Lonza) with 1% Human AB serum (Invitrogen) and 2 mM EDTA (Sigma-
Aldrich) supplemented with 50 U/mL DNase for 15 min at 37 °C. The epidermal
suspension was spun on a Ficoll-Paque PLUS (GE Healthcare Life Sciences, Little
Chalfont, United Kingdom) gradient and the immune cells harvested. Dermal cells
were enriched for CD45-expressing cells using CD45 magnetic bead separation
(Miltenyi Biotec,San Diego, CA, USA). Cell suspensions were then counted and/or
labelled for flow cytometric phenotyping of surface expression markers or for flow
sorting.
Flow cytometry and sorting. Cells were labelled in aliquots of 2.5 × 106 cells per
50 μl of buffer, according to standard protocols. Nonviable cells were excluded by
staining with Live/Dead™ Fixable Near-IR dead cell stain kit (Life Technologies).
Flow cytometry was performed on Becton Dickenson (BD) LSRFortessa flow
cytometer and data analysed by FlowJo (Treestar). FACS was performed on a BD
INFLUX (140 µm nozzle). Sorted cells were collected into FACS tubes containing
RPMI with 10% Fetal bovine serum (FBS). The antibodies were purchased from
BD, Miltenyi, BioLegend, Beckman Coulter, eBioscience and R&D Systems as
follows; BD: CD45 BV786
(HI30), HLA-DR, BUV395 (G46-6), CD1a BV510 (HI149), CD33 APC
(WM53), CXCR4 PE (12G5), CD4 APC (RPA-T4), CD80 PE (L307.4), CD83 APC
(HB15e), CD86 APC (2331
(FUN-1), CCR5 PE (2D7), DC-SIGN APC (DCN46), Clec12A AF647 (50C1),
EpCAM APC (EBA-1), MR APC & BV510 (19.2), Mouse IgG1 APC, Mouse IgG1
PE. Miltenyi: Clec7A PE (REA515), Clec9A PE (8F9), CD1c PE-Vio770 (AD5-
8E7), Siglec-5 APC (1A5), Langerin
Vioblue (MB22-9F5). Bio Legend: Siglec-1 PE (7-239), DEC205 PE (HD30).
Beckman Coulter: Langerin PE (DCGM4), MR PE (3.29B1.10). eBioscience: CD91
eFluor660 (A2MRa2). R&D Systems: L-SIGN PE (120604), DCIR PE (216110),
Clec4D PE (413512), Clec4G APC (845404), Clec5A APC (283834), Clec5C APC
(239127), Clec6A APC (545943),
Clec10A PE (744812), Clec14A APC (743940), Siglec-6 APC (767329), Siglec-9
APC (191240), Siglec-16 APC (706022). After Live/Dead Near- IR and surface
staining, HIV was detected by flow cytometry by incubating cytofix/cytoperm
solution (BD) for 15 min, washing with permwash (BD) and incubating with
antibodies to P24 PE (KC57, Beckman Coulter) and dual staining with either P24
APC (28b7, Medimabs) or utilising PrimeFlow™ (Thermofisher) for increased
sensitivity. PrimeFlow™ (AF647) was performed as per the manufacturer’s
instructions with a few minor changes. The target probe incubation was increased
to 3 h, the pre-amplification, amplification and label probe were increased to 2 h.
The concentration of the target probe was also increased from 1/20 to 1/10.
Cytometric bead arrays. Culture supernatants were collected from sorted epi-
dermal MNP subsets after 24 h culture with TLR agonist treatment (Pam2Cys
(5 µM), R848 (1 µg/ml) and LPS (1 µg/ml)), and stored at −80 °C until use. The
concentrations of TNF, IP-10, IL-10, IL-8, IL-6, IL-1β and IL-1α were analysed by
CBA (BD Biosciences), according to the manufacturer’s instructions for the
Human Soluble Protein Master Buffer Kit. Sample data was acquired with the BD
FACSCanto II flow cytometer and analysed using FCAP array software (BD
Biosciences). The standard range of detection for each cytokine was between
10–2500 pg/mL.
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RNA Seq. Cells isolated by flow cytometry (n= 200 cells per population) were
captured directly into lysis buffer containing 0.1% triton X-100, 1U RNaseOUT
RNase inhibitor (Life TechnologiesThermoFisher Scientific, Mulgrave, Australia),
2.5 mM each dNTP mix, 2.5 uM anchored oligo-dT primer (5′-AAGCAGTGG-
TATCAACGCAGAGTACT30VN-3′, Sigma-Aldrich, Castle Hill, Australia) in a
total volume of 20 μl. Full-length mRNA was reverse transcribed and amplified
using the Smart-seq2 protocol of Picelli et al.35,36: Aliquots of each cell lysis mix
were first heated to 72 °C for 3 min then placed on ice immediately. A first strand
reaction mix (6 μl) containing Superscript II reverse transcriptase (100 U, Life
Technologies-ThermoFisher Scientific), TSO primer (5′-AAGCAGTGGTAT-
CAACGCAGAGTACATrGrG+G-3′, 1 uM, Exiqon, Vedbaek, Denmark), 1 M
betaine (Sigma-Aldrich), 6 mM MgCl2 (Sigma-Aldrich), 5 mM DTT (Life
Technologies-ThermoFisher Scientific), RNaseOUT (10 U, Life Technologies-
ThermoFisher Scientific) and 2 μl 5X first strand buffer (Life Technolo-
giesThermoFisher Scientific), was added to each sample. Transcripts were reverse
transcribed by incubating at 42 °C for 60 min, followed by 10 cycles of 50 °C, 2 min
and 42 °C, 2 min. The resulting cDNAs were subsequently amplified by adding
12.5 μl KAPA HiFi 2X HotStart ReadyMix (KAPA Biosciences, Wilmington, MA),
10 μM ISPCR primer (0.25 μl, 5′AAGCAGTGGTATCAACGCAGAGT-3′, Sigma-
Aldrich) and 2.25 μl H2O and heating to 98 °C, 3 min, followed by 20 cycles of
98 °C, 20 s, 67 °C, 15 s, 72 °C, 6 min. After a final incubation at 72 °C, 5 min,
samples were held at 4 °C until purification. Samples were purified by addition of
Agencourt AMPure XP beads (1:1 v/v, Beckman Coulter, Lane Cove, Australia),
8 min, room temperature, followed by magnetic bead capture and two washes with
200 μl 80% ethanol. Beads were dried and cDNAs were eluted into 17.5 μl elution
buffer EB (Qiagen, Chadstone, Australia). Products were checked on Agilent
Bioanalyser High Sensitivity DNA chips and yield was estimated by Quant-iT
PicoGreen dsDNA Assay (Life TechnologiesThermoFisher Scientific). Sequencing
libraries were prepared from 1 ng cDNA product using Nextera XT reagents
(Illumina, Scoresby, Australia) in accordance with the supplier’s protocol except
that PCR was limited to eight cycles to minimise read duplicates, and final library
elution was performed using 17.5 μl elution buffer EB. Libraries were pooled and
sequenced on the Illumina HiSeq 2500 platform. Reads were aligned using STAR
v2.5.337 to the GRCh38 genome and were summarised to gene counts as annotated
by GENCODE v2638. Gene counts were normalised using TMM39 and variance
stabilised using DESeq240. Barnes-Hut tDistributed Stochastic Neighbor Embed-
ding with perplexity 10 was used to perform dimension reduction on the 231 genes
with average count greater than 20 and stabilised variance 50% higher than the
average.
QPCR. Total unamplified RNA was DNase I treated (Promega, Madison, WI)
and reverse transcribed using oligod(T) and superscript III (Invitrogen). The
cDNA was subject to QPCR using primers for CTSD, CD1E, NLRP3, ILR1R2,
RNASE1, CADM1, CLDN1, MMP12, ERG and GAPDH (Sigma-Aldrich) and
SYBR Green (Invitrogen). The data was analysed using the a standard curve
method17,21,22,26,31–34,41.
T cell proliferation assays. Epidermal MNP subsets were FACS sorted and added
to allogeneic T cells isolated from PBMC using CD3+ microbeads (Miltenyi) then
stained with Celltrace™ Violet (Thermofisher) as per the manufacturers instruction
at a ratio of 1:10 and cultured for 7 days. Positive (LCs+ PHA (5 µg /mL, Sigma-
Aldrich) and negative controls were also made up. Cells were then stained for Live/
Dead NIR and CD3 FITC, CD4 PE and CD8 APC and analysed on the BD
FACSCanto II.
Immunofluorescent staining of tissue. Four micrometre paraffin sections were
baked at 60 °C for 40 min, dewaxed in xylene and 100% ethanol and air dried.
Between all steps described herein, sections were washed three times in TBS
(Amresco, Cat: 0788) filled jars placed on a rotator for a total of 10 min. Antigen
retrieval was then performed using a ph9 antigen retrieval buffer (DAKO) in a
decloaking chamber (Biocare) for 20 min at 95 °C. Sections were incubated with 3%
H2O2 for 10 min and then blocked for 30 min (0.1% Saponin, 1% BSA, 10% donkey
serum). Primary antibody incubation was at 4 °C overnight. Antibodies for primary
detection include: Abcam – rabbit CD11c (EP1347Y), rabbit MR (polyclonal),
rabbit HLA-DR (EPR6148), mouse CD1c (2F4), mouse CollagenVII (LH7.2); R&D
- goat langerin (AF2088). Sections were then incubated with secondary antibodies
for 30 min at RT. Donkey secondary antibodies (molecular probes) against rabbit,
mouse or goat were used and were conjugated to either alexa fluor 488, 546 or 647
or HRP. For HRP-labelled secondaries tyramide-FITC (perkin elmer) was then
applied for 10 min at RT. Sectioned were then DAPI stained and mounted using
slowfade diamond antifade (molecular probes).
Immunofluorescence microscopy. Tissue sections were imaged using x40 objec-
tive on either a Deltavision restoration microscope with a Photometrics CoolSnap
QE camera (GE Healthcare, IL) (images in Fig. 2), or the InCell 2200 (GE
Healthcare, IL) (images in Fig. 5). Images were then deconvolved and stitched
using either SoftWoRx (version 6.1.3) for Deltavision images, or InCell analyser
software for InCell images (GE Healthcare, IL). All subsequent image analysis was
performed using Fiji (Madison version).
In some cases multiple Z-planes were imaged using a x60 objective on the
Deltavision System with 0.1 um z-spacing (Transmitted/Founder HIV images in
Fig. 6e and Supplementary Fig. 3). Huygens Professional 18.10 (Scientific Volume
Imaging, The Netherlands, http://svi.nl) CMLE algorithm, with SNR:20 and 40
iterations, was used for deconvolution of Z-stacks. XY, XZ, YZ projections were
generated using the Huygens Orthoslicer feature.
Ex vivo inner foreskin explants. Healthy Inner foreskin explants were infected
with either HIVBal or Transmitted/Founder HIV1 Z3678M using an explant setup.
Briefly, pyrex cloning cylinders (8 × 8 mm, Sigma-Aldrich) were dipped in his-
toacryl surgical glue (B Braun) and placed over the mucosal surface of the tissue.
We then cut around the cloning cylinders and loaded the explant tissues onto gel-
foam sponges (Pfizer) soaked in culture media in a 24-well plate. Culture media
consisted of 10 μM HEPES (Gibco), non-essential amino acids (Gibco), 1 mM
sodium pyruvate (Gibco) 50 μM 2-Mercaptoethanol (Gibco), 10 μg/ml Gentamycin
(Gibco) and 10% fetal calf-serum, all diluted in RPMI (Lonza). Wells were filled
with culture media to just below the tissue surface level and PBS was then added to
the inner chamber of the cloning cylinders to prevent the surface from drying and
to assist with setting of the glue. For infection, PBS was removed from the
chambers and virus at a TCID50 of 3500 (diluted in 100 μl PBS) was added for
2–3 h at 37 °C. At the end of the culture period, solutions were aspirated from the
cloning cylinder and the surface was washed three times with PBS to remove virus
resting on the tissue surface. Cloning cylinders were removed and placed in
4% PFA (diluted in PBS) (electron microscopy sciences) for 18–24 h at room
temperature. Prior to paraffin embedding, tissues were trimmed along the mark left
by the cloning cylinder so that only the infected area remained.
RNAscope. Detection of HIV RNA was performed using the ‘RNAscope 2.5HD
Reagent Kit-RED’ (Cat: 322360, ACD Bio) as described previously21 with custom
probes (consisting of 85 zz pairs) against HIV-1BaL (REF: 486631, ACD Bio)
spanning base pairs 1144–8431 of HIV-1BaL sequence. This probe was also used for
the detection of HIV-1 Z3678M. In the protocol described below, reagents from
‘RNAscope 2.5HD Reagent Kit-RED’ are indicated with ‘RNAscope kit’ in brackets
after the reagent name. Unless otherwise indicated wash steps with each solution
were carried out for 2 min on a rotator set to low. All 40 °C incubations were
carried out in a hybridisation oven (HybEZ Hybridization System (220VAC) With
ACD EZBatch Slide System, ACD Bio).
Four micrometre paraffin sections from infected tissue blocks were baked,
dewaxed and antigen retrieval performed as described above in
‘Immunofluorescent Staining of Tissue’. Sections were then washed with Milli-Q
water, followed by TBS (Amresco, Cat: 0788) and then immersed in a 300 mM
Glycine (Amresco, Cat: 0167) solution, (diluted in TBS) for 1.5 h at room temp.
Sections were washed in TBS, followed by Milli-Q water, then dipped 3–5 times in
100% ethanol, allowed to air dry then encircled with a hydrophobic pen. Sections
were then covered with protease pre-treatment 3 (RNAscope kit) and incubated for
30 min in a hybridisation oven set to 40 °C. Sections were washed twice in Milli-Q
water and a custom probe against HIV-1BaL (REF: 486631, ACD Bio) or DapB
negative probe control (cat: 310043, RNAscope kit,) was applied to sections for 2 h
at 40 °C. Sections were washed twice with RNAscope wash buffer (RNAscope kit).
Six amplification reagents labelled Amp 1–6 (RNAscope kit) were then applied
sequentially to the tissue sections with two washes in RNAscope wash buffer in
between each incubation. Amp 1= 30 min at 40 °C; Amp 2= 15 min at 40 °C;
Amp 3= 30 min at 40 °C; Amp 4= 15 min at 40 °C; Amp 5= 30 min at room
temp; Amp 6= 15 min at room temp. HIV RNA was then developed using a Fast
Red chromagen solution made by mixing Red-B and Red-A (RNAscope kit) in a
1:60 ratio and applying to sections at room temp for 2 min. Sections were then
washed in Milli-Q water followed by 0.1% Tween-20 (diluted in TBS).
Immunofluorescent staining against cell surface markers was then carried out as
described in ‘Immunofluorescent Staining of Tissue’, starting from the application
of 3% H2O2 to tissue sections. Sections were then imaged on the InCell 2200 using
channels FITC (Ex: 490/20, Em: 525/36), Cy3 (Ex: 543/22, Em: 605/64), Cy5 (Ex:
645/30, Em: 705/72).
MNP-CD4 T cell HIV transfer assay. Epidermal mononuclear phagocytes were
isolated from abdominal skin using collagenase digestion and LCs, CD11chiDCs
and CD33low cells sorted by FACS. A minimum of 3 × 104 of each cell population
was then infected with HIVBaL at MOI= 1 for 2 h and the virus washed off using
3x PBS washes. Infected cells were then cultured human skin fibroblast conditioned
media to enhance cell survival15 and JLTR CD4 T cells (which express GFP under
control of the HIV-1 promotor10 were added at ratio of 4:1 after 96 h and co-
cultured for a further 96 h. The percentage of GFP+ JLTR cells was then deter-
mined by flow cytometry. Transfer assays with HIVZ3678M were performed as
above, except CD4 T cells isolated (CD4 T cell negative selection kit, Stemcell) from
PBMCs activated for 3 days with PHA (5 µg/mL) and IL-2 (150 IU/mL, Peprotech)
were added at a ratio of 2:1 and co-cultured for a further 72 h prior to staining with
Live/Dead Near-IR and intracellularly for P24 (KC57)-PE. For Inhibition experi-
ments, sorted MNPS were pre-treated for 1 h with 10 µM Maraviroc (kindly gifted
by Paul Gorry, Melbourne), HIV was added for 2 h, cells were washed and cultured
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10697-w ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2759 | https://doi.org/10.1038/s41467-019-10697-w |www.nature.com/naturecommunications 13
for a further 96 h in the presence of maraviroc. At 96 h, maraviroc was washed off
prior to the addition of JLTR cells for a further 96 h.
Statistical analysis. Statistical analysis and graphs were produced using Graphpad
Prism (version 7.02) and show mean ± standard deviation unless stated otherwise.
Normalised distribution was not assumed to account for donor-to-donor varia-
bility, thus statistics were produced using an unpaired nonparametric
Mann–Whitney t test or a Wilcoxon test for paired data. Results were considered
statistically significant when P ≤ 0.05. Significance levels were ns; *p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001 as suggested by Graphpad Prism.
In situ quantification. In situ quantification was performed using Fiji (Madison
version) and included distance measurements and measurements of HIV-cell
interactions.
The distance of Epidermal CD11c+ cells and Langerhan’s Cells to the basement
membrane (Fig. 6b) was calculated as follows: (1) the basement membrane was
manually outlined and a Euclidean Distance Map (EDM) map was generated
emanating from the basement membrane. (2) Each cell type was manually outlined
and stored in the ImageJ Region of Interest (ROI) manager. (3) The mean pixel
intensity of each ROI on the EDM map was calculated. (4) Distance measurements
were extracted by converting pixel units to microns using the original image
resolution.
HIV-cell interactions (Fig. 6e) were calculated as follows: (1) The epidermis was
manually outlined and stored in the ROI manager. (2) Binary masks of Epidermal
CD11c+ cells (CD11c+), LCs (CD11c-Langerin+) and HIV were generated using
a manual threshold. (3) The ImageJ calculator ‘AND’ function was used to extract
the intersection of CD11c+ cells and HIV, or LCs and HIV. (4) The area of the
intersection mask was measured within the epithelium to estimate the overlap of
each cell type with HIV.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. Source data used to generate Figs. 1, 4–7 and
Supplemental Fig. 2 are provided in the Source Data file. The RNA sequencing data have
been deposited in the Gene Expression Omnibus (GEO) database under accession code:
GSE130804.
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